ARRAY BIOPHARMA INC Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARRAY BIOPHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARRAY BIOPHARMA INC for June 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Option Exercise | M | 0.00 | 11,453 | 0 | 0 | |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Payment of Exercise | F | 18.50 | 5,038 | 93,203 | 61,693 | 66.7 K to 61.7 K (-7.55 %) |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Saccomano Nicholas A | CSO | Buy | M | 0.00 | 11,453 | 0 | 66,731 | 55.3 K to 66.7 K (+20.72 %) |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Option Exercise | M | 0.00 | 32,068 | 0 | 0 | |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Sell | S | 17.74 | 17,964 | 318,681 | 159,467 | 177.4 K to 159.5 K (-10.12 %) |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Payment of Exercise | F | 18.50 | 14,104 | 260,924 | 177,431 | 191.5 K to 177.4 K (-7.36 %) |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Robbins Andrew R | COO | Buy | M | 0.00 | 32,068 | 0 | 191,535 | 159.5 K to 191.5 K (+20.11 %) |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 8.79 | 140,625 | 1,236,094 | 421,875 | |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Option Exercise | M | 0.00 | 77,881 | 0 | 0 | |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Sell | S | 18.03 | 140,625 | 2,535,469 | 211,575 | 352.2 K to 211.6 K (-39.93 %) |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 8.79 | 140,625 | 1,236,094 | 352,200 | 211.6 K to 352.2 K (+66.47 %) |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Sell | S | 17.74 | 43,628 | 773,961 | 211,575 | 255.2 K to 211.6 K (-17.10 %) |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Payment of Exercise | F | 18.50 | 34,253 | 633,681 | 255,203 | 289.5 K to 255.2 K (-11.83 %) |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Squarer Ron | CEO | Buy | M | 0.00 | 77,881 | 0 | 289,456 | 211.6 K to 289.5 K (+36.81 %) |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 0.00 | 17,440 | 0 | 0 | |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Payment of Exercise | F | 18.50 | 7,753 | 143,431 | 219,773 | 227.5 K to 219.8 K (-3.41 %) |
| Jun 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Buy | M | 0.00 | 17,440 | 0 | 227,526 | 210.1 K to 227.5 K (+8.30 %) |
| Jun 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 4.36 | 7,500 | 32,700 | 0 | ||
| Jun 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Option Exercise | M | 5.13 | 14,000 | 71,820 | 11,000 | ||
| Jun 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Sell | S | 19.08 | 21,500 | 410,220 | 19,297 | 40.8 K to 19.3 K (-52.70 %) | |
| Jun 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 5.13 | 14,000 | 71,820 | 40,797 | 26.8 K to 40.8 K (+52.24 %) | |
| Jun 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | VAN LUNSEN GIL J | Buy | M | 4.36 | 7,500 | 32,700 | 26,797 | 19.3 K to 26.8 K (+38.87 %) | |
| Jun 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 3.65 | 77,576 | 283,152 | 279,259 | |
| Jun 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Sell | S | 18.76 | 77,576 | 1,455,326 | 210,086 | 287.7 K to 210.1 K (-26.97 %) |
| Jun 21 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Buy | M | 3.65 | 77,576 | 283,152 | 287,662 | 210.1 K to 287.7 K (+36.93 %) |
| Jun 15 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Option Exercise | M | 3.65 | 22,424 | 81,848 | 356,835 | |
| Jun 15 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Sell | S | 18.75 | 22,424 | 420,450 | 210,086 | 232.5 K to 210.1 K (-9.64 %) |
| Jun 15 2018 | ARRY | ARRAY BIOPHARMA IN ... | Sandor Victor | Chief Medical Offic ... | Buy | M | 3.65 | 22,424 | 81,848 | 232,510 | 210.1 K to 232.5 K (+10.67 %) |